Long-Acting β<sub>2</sub>-Agonist Step-off in Patients With Controlled Asthma
Jan Brożek(Cochrane), Thomas B. Casale(University of South Florida), Michelle M. Cloutier(Connecticut Children's Medical Center), Stephen C. Lazarus(University of California, San Francisco), Monica Kraft(Duke Medical Center), Jerry A. Krishnan(Chicago Department of Public Health), James T. Li(Mayo Clinic in Arizona), Robert C. Strunk(Washington University in St. Louis), Nancy Santesso(McMaster University)
Cited by 63
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k